NEWARK, DE / ACCESSWIRE / June 6, 2023 / The Bacteriophage Market is registering a valuation of US$ 45.07 million in 2023 and is projected to reach US$ 68.0 million by 2033. The market is securing a CAGR of 4.2% during the forecast period.
How Research Institutions Are Improving the Bacteriophage Usage?
The research institutions are experimenting with Bacteriophages to treat bacterial infections. These institutions are potentially working to provide better therapy. The research institutions are contributing their role in several ways are:
- Isolate New Bacteriophage: Researchers separate specific Bacteriophages that from another bacterial strain. It allows them to develop new targeted therapies to treat specific infections.
- Develop Bacteriophage Cocktails: The research institutions develop Bacteriophage cocktails to target various bacterial strains. It helps to increase the efficacy of therapy and reduce bacterial resistance.
- Optimization: The researchers experiment with various delivery methods such as topical cream, aerosol sprays and intravenous injections for Bacteriophage. This approach can kill targeted bacteria.
- Safety: Researchers provide safety for Bacteriophage in the uses of humans. This testing requires potential monitoring and side effects to treat patients.
For an overview of Vendors and Their Offerings - Request your Sample Report here @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14461
Top Highlights from FMI's Analysis:
- The Bacteriophage market is anticipated to capture a valuation of US$ 68.0 million with a CAGR of 4.2% by 2033.
- The United States is predicted to secure a share of 26.3% in the global market during the forecast period.
- With a share of 3.1%, Japan is anticipated to grow significantly in the global market by 2033.
- Historically, the market registered a valuation of US$ 43.2 million in 2022.
- In the historic period, the market captured a CAGR of 3.6% between 2018 and 2022.
How Key Players are Booming the Global Market?
The market is growing by the number of key players that invest in research and development activities to uplift the market revenue. The prominent players play a crucial role in staying ahead of competitors through their strategies. These strategies are collaborations, mergers, agreements, partnerships and acquisitions. The key players in the market are mentioned below:
- Phage International: The company is focused on providing improved Bacteriophage products to treat patients' bacterial infections.
- BioDome: BioDome is a biotechnology company offering Bacteriophage products for agriculture.
- AmpliPhi Biosciences: The company develop Bacteriophage therapies to treat patients' infections related to bacteria.
- Intralytix: The company develop products related to Bacteriophage to treat illness related foodborne.
- Pherecydes: Pherecydes is a French-based company developing improved products to treat infections.
Key Developments in this Market:
- In 2021, Armata Pharmaceuticals launched its new clinical trial product AP-SA02 initiative to treat Staphylococcus aureus infections.
- In 2021, Eliava BioPreparations newly launched its product ELP-1 phage lysate. This product is derived from Proteus mirabilis and E. coli.
- In 2021, Adaptive Phage Therapeutics launched phage therapy to treat Pseudomonas aeruginosa infections.
- In 2021, Locus Biosciences announced its phase 1b clinical trial to treat urinary tract infections caused by Escherichia coli.
- In 2021, Pherecydes Pharma announced it to receive US$ 20 million from European Investment Bank to develop phage therapy to treat bacterial infections.
Ask for more pointers about Analysis on Top Regions @ https://www.futuremarketinsights.com/ask-question/rep-gb-14461
Major Players:
- Life extension
- Arthur Andrew Medical
- Deerland Probiotics & Enzymes Inc.
- BioChimpharm
- Micreos Human Health
- Designs for Health
- Accelerated Health Systems LLC
- The biostation
- Microgen
- IntraLytix Inc
Key Segments in this Market are:
By Product Type:
- Phage Probiotics
- Phage Therapeutics
By Route of Administration:
- Oral
- Topical
- Other
By Application:
- Gastroenterology
- Respiratory Infections Market
- Skin Infection Treatment
- Wound Prophylaxis
- Urogenital Infection Treatment
- Others
By Distribution Channel:
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
Request Methodology @ https://www.futuremarketinsights.com/request-report-methodology/rep-gb-14461
Table of Content (ToC):
1. Executive Summary | Bacteriophage Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter's Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Product, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product, 2023 to 2033
5.3.1. Phage Probiotics
5.3.2. Phage Therapeutics
5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Route of Administration
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Route of Administration, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Route of Administration, 2023 to 2033
6.3.1. Oral
6.3.2. Topical
6.3.3. Others
6.4. Y-o-Y Growth Trend Analysis By Route of Administration, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Route of Administration, 2023 to 2033
Buy Now to Gain Access to Detailed Information About Each Segment and Identify Key Trends, Drivers, and Challenges in the Market @https://www.futuremarketinsights.com/checkout/14461
Have a Look at Related Reports of the Healthcare domain:
Advance Wound Dressing Market Size: The advanced wound dressing market size was valued at $8,978.0 million in 2020, and is projected to reach US$ 14,190.5 million by 2030, registering a CAGR of 4.8%
Hemostats For Wound Closure Market Share: The Hemostats For Wound Closure Market is expected to register a CAGR of 6.3% during the forecast period, up from US$ 2.4 Billion in 2021 to reach a valuation of US$ 3.5 Billion by 2026.
Wound Evacuators Market Demand: Wound Evacuator sales are projected to grow at a steady CAGR of 4.1% between 2022 and 2032, generating revenues worth US$ 593.6 Million by the end of 2032.
Regenerative Artificial Skin Market Analysis: Regenerative Artificial Skin is projected to grow at a CAGR of 9.9% between 2022 and 2032, totalling around US$ 5,615.5 Million by 2032.
Skin Perfusion Pressure Testing Devices Market Trends: The rising prevalence of peripheral artery disease and the increasing incidence of chronic limb ischemia has necessitated innovation in skin perfusion pressure testing devices.
Respiratory Pathogen Testing Kits Market Growth: As per the latest market research conducted by FMI, the global respiratory pathogen testing kits market is expected to record a CAGR of 5.7% from 2023 to 2033.
Therapeutic Respiratory Devices Market Forecast: The therapeutic respiratory devices market is estimated to attain a market value of US$ 50.6 billion in the year 2023. From the period 2023 to 2033, the market is assessed to reach US$ 80.2 billion by 2033, registering a CAGR of 4.7%.
Respiratory Heaters Market Status: The global demand for respiratory heaters is presently valued at around US$ 1.3 Million and is projected to reach US$ 3.7 Million by 2032.
Gastrointestinal Rare Diseases Treatment Market Overview: The global gastrointestinal rare diseases treatment market garnered a market value of US$ 1,314.8 Million in 2022 and is expected to accumulate a market value of US$ 1,965 Million by registering a CAGR of 3.7% in the forecast period 2022 to 2032.
Genital Herpes Treatment Market Outlook: Future Market Insights (FMI) in its latest market analysis forecasts that genital herpes treatment sales will accelerate at 1.5x in the next ten years reaching a market valuation of US$ 2881.8 Million by the end of 2031.
About Future Market Insights (FMI):
Future Market Insights, Inc. (ESOMAR certified, Stevie Award - recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10 years.
Contact Us:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: [email protected]
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn | Twitter | Blogs
SOURCE: Future Market Insights, Inc.